Scarica l'app Stockscreener
0.7605
2.50%
-0.0195
Dopo l'orario di chiusura:
.76
-0.0005
-0.07%
Precedente Chiudi:
$0.78
Aprire:
$0.782
Volume 24 ore:
60,495
Relative Volume:
0.10
Capitalizzazione di mercato:
$73.16M
Reddito:
-
Utile/perdita netta:
$-72.73M
Rapporto P/E:
-1.3703
EPS:
-0.555
Flusso di cassa netto:
$-80.33M
1 W Prestazione:
-7.26%
1M Prestazione:
+8.64%
6M Prestazione:
-42.98%
1 anno Prestazione:
-63.08%
Intervallo 1D:
$0.75
$0.81
Intervallo di 1 settimana:
$0.75
$0.827
Portata 52W:
$0.5024
$2.14
Dbv Technologies Adr Stock (DBVT) Company Profile
Nome
Dbv Technologies Adr
Settore
Industria
Telefono
33(0)155427878
Indirizzo
107 AVENUE DE LA REPUBLIQUE, CHATILLON
Dbv Technologies Adr Stock (DBVT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-01-04 | Aggiornamento | Societe Generale | Hold → Buy |
| 2022-12-16 | Downgrade | Goldman | Neutral → Sell |
| 2022-05-10 | Downgrade | Goldman | Buy → Neutral |
| 2021-09-14 | Aggiornamento | Societe Generale | Hold → Buy |
| 2021-01-22 | Downgrade | Societe Generale | Hold → Sell |
| 2020-11-02 | Aggiornamento | Societe Generale | Sell → Hold |
| 2020-08-06 | Downgrade | Societe Generale | Buy → Sell |
| 2020-08-05 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-17 | Downgrade | Stifel | Buy → Hold |
| 2020-01-09 | Aggiornamento | Stifel | Hold → Buy |
| 2019-12-16 | Iniziato | Citigroup | Buy |
| 2019-09-05 | Ripresa | Morgan Stanley | Equal-Weight |
| 2019-06-17 | Iniziato | Goldman | Buy |
| 2018-12-20 | Downgrade | Barclays | Overweight → Equal Weight |
| 2018-12-20 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2018-12-20 | Downgrade | Jefferies | Buy → Hold |
| 2018-12-20 | Downgrade | Stifel | Buy → Hold |
| 2017-10-31 | Aggiornamento | Societe Generale | Sell → Hold |
| 2017-10-24 | Downgrade | Societe Generale | Buy → Sell |
| 2017-10-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2017-06-23 | Iniziato | Deutsche Bank | Buy |
| 2017-03-16 | Aggiornamento | Societe Generale | Hold → Buy |
| 2016-09-26 | Iniziato | JMP Securities | Mkt Outperform |
| 2015-12-03 | Iniziato | Barclays | Overweight |
| 2015-10-23 | Iniziato | BofA/Merrill | Buy |
Mostra tutto
Dbv Technologies Adr Borsa (DBVT) Ultime notizie
European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - MSN
DBV Technologies (NASDAQ:DBVT) Receives New Coverage from Analysts at StockNews.com - MarketBeat
DBV Technologies (NASDAQ:DBVT) Research Coverage Started at StockNews.com - Defense World
European Equities Traded in the US as American Depositary Receipts Gain Wednesday - MSN
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading - MSN
HC Wainwright Forecasts Higher Earnings for DBV Technologies - Defense World
European Equities Traded in the US as American Depositary Receipts Rise Slightly Higher in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading - MSN
Data-Based Insights About DBV Technologies ADR (DBVT) - Stocks Register
HC Wainwright Has Positive Forecast for DBVT FY2024 Earnings - MarketBeat
GSK Plc ADR (GSK): An Important Analyst Insights - Stocks Register
Paramount Global (NASDAQ: PARA): Blank Check On Growth? - Stocks Register
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading - MSN
H.C. Wainwright raises DBV Technologies shares price target, keeps Buy rating - Investing.com India
DBV Technologies (NASDAQ:DBVT) PT Raised to $7.00 - MarketBeat
DBV Technologies ADR (NASDAQ: DBVT) Is The Number One Stock Currently Moving. - Stocks Register
Atlantic Union Bankshares Corp Still Hasn’t Convinced Analysts? - Stocks Register
DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe - GlobeNewswire
DBV Technologies (NASDAQ:DBVT) Coverage Initiated by Analysts at StockNews.com - Defense World
StockNews.com Begins Coverage on DBV Technologies (NASDAQ:DBVT) - MarketBeat
DBV Technologies to Participate in Upcoming ACAAI 2024 Congress - The Manila Times
Peanut Protein Patch Market Report to 2032 -DBV Technologies, Segment - IndiaPolitics.com
DBV Technologies (NASDAQ:DBVT) Now Covered by Analysts at StockNews.com - MarketBeat
DBV Technologies SA (DBVT) (Q2 2024) Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance
European Equities Traded in the US as American Depositary Receipts Tread Water in Wednesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading - MSN
Point72 Asset Management L.P. Cuts Stock Position in DBV Technologies S.A. (NASDAQ:DBVT) - MarketBeat
European Equities Traded in the US as American Depositary Receipts Higher in Wednesday Trading - MSN
Short Interest in DBV Technologies S.A. (NASDAQ:DBVT) Expands By 7.1% - MarketBeat
European Equities Traded in the US as American Depositary Receipts Flat in Friday Trading - MSN
Wall Street SWOT: DBV Technologies stock faces pivotal phase in peanut allergy treatment - Investing.com
European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - MSN
Wall Street SWOT: DBV Technologies stock faces pivotal phase in peanut allergy treatment By Investing.com - Investing.com South Africa
DBV Technologies' (DBVT) Market Outperform Rating Reiterated at JMP Securities - MarketBeat
JMP Securities Reiterates "Market Outperform" Rating for DBV Technologies (NASDAQ:DBVT) - MarketBeat
JMP Securities Reiterates “Market Outperform” Rating for DBV Technologies (NASDAQ:DBVT) - Defense World
DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial - GlobeNewswire
(ADME) Pivots Trading Plans and Risk Controls - Stock Traders Daily
DEADLINE ALERT for ABR, FIVE, DXC, and INDV: The Law - GlobeNewswire
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading - MSN
Arkade Developers IPO Allotment Finalised: How to Check Status Online, Know GMP Today, Listing Date - News18
Arkade Developers IPO Allotment Today: A Step-by-Step Guide to Check Status Online, Know Latest GMP - News18
DBV Technologies S.A. (NASDAQ:DBVT) Short Interest Down 5.1% in August - Defense World
Arkade Developers IPO Day 3: Check Subscription Status, GMP, Review - News18
Dbv Technologies Adr Azioni (DBVT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Dbv Technologies Adr Azioni (DBVT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Mohideen Pharis | Chief Medical Officer |
May 24 '24 |
Sale |
1.36 |
660 |
898 |
81,152 |
| Mohideen Pharis | Chief Medical Officer |
May 22 '24 |
Sale |
1.38 |
382 |
527 |
81,812 |
| Tasse Daniel | CHIEF EXECUTIVE OFFICER |
Mar 08 '24 |
Buy |
0.83 |
17,094 |
14,188 |
17,094 |
| Ndu Adora | Director |
Feb 06 '24 |
Buy |
0.89 |
1,825 |
1,624 |
1,825 |
| Mohideen Pharis | Chief Medical Officer |
Nov 22 '23 |
Sale |
1.74 |
2,245 |
3,906 |
82,194 |
2.02%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):